X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
94
PharmaCompass offers a list of Ulipristal Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ulipristal Acetate manufacturer or Ulipristal Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ulipristal Acetate manufacturer or Ulipristal Acetate supplier.
PharmaCompass also assists you with knowing the Ulipristal Acetate API Price utilized in the formulation of products. Ulipristal Acetate API Price is not always fixed or binding as the Ulipristal Acetate Price is obtained through a variety of data sources. The Ulipristal Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ulipristal Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ulipristal Acetate, including repackagers and relabelers. The FDA regulates Ulipristal Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ulipristal Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ulipristal Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ulipristal Acetate supplier is an individual or a company that provides Ulipristal Acetate active pharmaceutical ingredient (API) or Ulipristal Acetate finished formulations upon request. The Ulipristal Acetate suppliers may include Ulipristal Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Ulipristal Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ulipristal Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ulipristal Acetate active pharmaceutical ingredient (API) in detail. Different forms of Ulipristal Acetate DMFs exist exist since differing nations have different regulations, such as Ulipristal Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ulipristal Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Ulipristal Acetate USDMF includes data on Ulipristal Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ulipristal Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ulipristal Acetate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ulipristal Acetate Drug Master File in Japan (Ulipristal Acetate JDMF) empowers Ulipristal Acetate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ulipristal Acetate JDMF during the approval evaluation for pharmaceutical products. At the time of Ulipristal Acetate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ulipristal Acetate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ulipristal Acetate Drug Master File in Korea (Ulipristal Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ulipristal Acetate. The MFDS reviews the Ulipristal Acetate KDMF as part of the drug registration process and uses the information provided in the Ulipristal Acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ulipristal Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ulipristal Acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ulipristal Acetate suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ulipristal Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ulipristal Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ulipristal Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ulipristal Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ulipristal Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ulipristal Acetate suppliers with NDC on PharmaCompass.
Ulipristal Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ulipristal Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ulipristal Acetate GMP manufacturer or Ulipristal Acetate GMP API supplier for your needs.
A Ulipristal Acetate CoA (Certificate of Analysis) is a formal document that attests to Ulipristal Acetate's compliance with Ulipristal Acetate specifications and serves as a tool for batch-level quality control.
Ulipristal Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Ulipristal Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ulipristal Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ulipristal Acetate EP), Ulipristal Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ulipristal Acetate USP).
Market Place
